These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16392319)

  • 1. [Risk of cardiovascular disease associated to chronic renal disease. Prevalence and control degree of classical risk factors].
    García de Vinuesa S; Gómez-Campderá F; Goicoechea MA; Luño J
    Nefrologia; 2005; 25 Suppl 4():18-22. PubMed ID: 16392319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular, renal and other chronic diseases. Early intervention is necessary in chronic kidney disease].
    Martín de Francisco AL; Aguilera L; Fuster V
    Nefrologia; 2009; 29(1):6-9. PubMed ID: 19240765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid-lowering therapy in chronic kidney disease].
    Fernández-Vega F
    Nefrologia; 2004; 24 Suppl(6):113-26, 187-235. PubMed ID: 15696902
    [No Abstract]   [Full Text] [Related]  

  • 4. The CARI guidelines. Cardiovascular risk factors. Lipid-lowering therapy in patients with chronic kidney disease.
    Walker R;
    Nephrology (Carlton); 2005 Dec; 10 Suppl 5():S231-4. PubMed ID: 16371108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition interventions to address cardiovascular outcomes in chronic kidney disease.
    Beto JA; Bansal VK
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):391-7. PubMed ID: 15492977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of chronic kidney disease in community-dwelling elderly and associated cardiovascular risk factors].
    Almirall J; Vaqueiro M; Antón E; Baré ML; González V; Jaimez E; Gimeno C;
    Nefrologia; 2005; 25(6):655-62. PubMed ID: 16514906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic renal disease in renal transplant patients: management of cardiovascular risk factors.
    Fernández-Fresnedo G; Gómez-Alamillo C; Ruiz JC; de Francisco AL; Arias M
    Transplant Proc; 2009 Jun; 41(5):1637-8. PubMed ID: 19545697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
    Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):889-97. PubMed ID: 17702732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid abnormalities and cardiovascular risk in renal disease.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
    Bianchi ME; Farías EF; Bolaño J; Massari PU
    Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis and Folic Acid Supplementation Trial: untangling the web of cardiac risk in chronic kidney disease.
    Kelly JJ; Kohlhagen J
    Nephrology (Carlton); 2004 Jun; 9(3):112-3. PubMed ID: 15189169
    [No Abstract]   [Full Text] [Related]  

  • 16. Candidate risk factors for cardiovascular disease in CKD.
    De Santo NG; Cirillo M; Perna A; Iacono G; Capasso G
    Semin Nephrol; 2006 Jan; 26(1):1-2. PubMed ID: 16412816
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand?
    Hou FF
    Chin Med J (Engl); 2005 Jun; 118(11):883-6. PubMed ID: 15978187
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
    McCullough PA; Haapio M; Mankad S; Zamperetti N; Massie B; Bellomo R; Berl T; Anker SD; Anand I; Aspromonte N; Bagshaw SM; Bobek I; Cruz DN; Daliento L; Davenport A; Hillege H; House AA; Katz N; Maisel A; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Shaw A; Sheinfeld G; Soni S; Vescovo G; Zanco P; Ronco C; Berl T;
    Nephrol Dial Transplant; 2010 Jun; 25(6):1777-84. PubMed ID: 20375030
    [No Abstract]   [Full Text] [Related]  

  • 19. MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients.
    Van Zuilen AD; Wetzels JF; Bots ML; Van Blankestijn PJ;
    J Nephrol; 2008; 21(3):261-7. PubMed ID: 18587712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.